Research / FCUV / Fundamental state Inspectable configuration
State dimensions Filing 0001683168-19-003607 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.05% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-195.24% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
138.80% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 40th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
24.89% · OPTIONAL · VALID
Gross margin 0th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
-4.88% · CORE · VALID
Operating margin 10th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
-522.51% · CORE · VALID
R&D intensity 10th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
19.95% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.60% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 5/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 8.61%
Current 1.05%
Delta -7.55% Cash Generation Decreased
Previous -19.46%
Current -195.24%
Delta -175.78% Growth Decreased
Previous 956.65%
Current 138.80%
Delta -817.86% Inventory Pressure Increased
Previous 21.05%
Current 24.89%
Delta 3.84% Margin Decreased
Previous 32.92%
Current -4.88%
Delta -37.80% Profitability Decreased
Previous -117.14%
Current -522.51%
Delta -405.37% R And D Intensity Increased
Previous 15.40%
Current 19.95%
Delta 4.56% Sbc Intensity Increased
Previous 2.85%
Current 3.60%
Delta 0.75% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.